Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer

BACKGROUND: Thymoquinone (TQ) was shown to reduce tumor growth in several cancer models both in vitro and in vivo. So far only a few targets of TQ, including protein kinases have been identified. Considering that kinases are promising candidates for targeted anticancer therapy, we studied the comple...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: El-Baba, Chirine, Mahadevan, Vijayalakshmi, Fahlbusch, Fabian B, S, Suma Mohan, Rau, Tilman T, Gali-Muhtasib, Hala, Schneider-Stock, Regine
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2014
الموضوعات:
Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4158125/
https://ncbi.nlm.nih.gov/pubmed/25174975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-201
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة